Tag Archives: MHRA

Packaging: Regulators Call for Better Patient Information

By Jacob Presson, Research Analyst at Cutting Edge Information. Regulations concerning the contents of patient package inserts (known in the EU as “patient information leaflets” or PILs) have in the past erred on the side of caution, making sure that all of the necessary information about side effects and cross-prescription conflicts was included. Pharmaceutical companies […]
Posted in Europe, Global, Guest Blog, healthcare, patient education, Regulatory, Strategy | Also tagged , , , , | Leave a comment
  • Categories

  • Meta